Black Diamond Therapeutics (BDTX)
(Real Time Quote from BATS)
$4.34 USD
-0.24 (-5.24%)
Updated Sep 25, 2024 10:44 AM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Company Summary
Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.
Company Summary
General Information
Black Diamond Therapeutics, Inc
ONE MAIN STREET 14TH FLOOR
CAMBRIDGE, MA 02142
Phone: 617-252-0848
Fax: NA
Web: NA
Email: investors@bdtherapeutics.com
Industry | Medical - Biomedical and Genetics |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/4/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.35 |
Current Year EPS Consensus Estimate | -1.40 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 11/4/2024 |